Valsartan 80 mg Tablet
Valsartan
Prescription medication
Hallym Pharmaceutical Co., Ltd.
MFDS item code 201105416 · Notified 2011.08.18
This product's status changed to Approval withdrawn on 2023.07.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension and heart failure (intolerance to ACE inhibitors), reduction of mortality risk after myocardial infarction
This medication is used to reduce the risk of death in patients with essential hypertension, heart failure intolerant to ACE inhibitors, and left ventricular dysfunction after myocardial infarction.
Essential hypertension: Recommended oral dosage is 80 mg once daily. If blood pressure control is insufficient, the dosage may be increased to 160 mg per day, with a maximum of 320 mg. Elderly patients (75 years and older): Start with 40 mg once daily. Heart failure: Recommended oral dosage is 40 mg twice daily, with a possibility of increasing to 80 mg or 160 mg per dose. The maximum dose per day is 320 mg.
This medication may cause serious harm to the fetus when taken during pregnancy, particularly in the second and third trimesters, so if pregnancy is confirmed, treatment must be discontinued immediately. It should not be used in patients with an allergy to this drug, severe liver or kidney disease, or a history of specific angioedema. Elderly patients, patients with hyperkalemia, those with impaired hepatic function, and those with heart or vascular issues should be monitored more carefully during administration, as hypotension or changes in renal function may occur. Dizziness or symptoms of hypotension may occur while taking this medication; therefore, caution is needed when driving or operating machinery. Patients who are likely to have elevated potassium levels or are taking potassium-sparing diuretics should have their serum potassium levels monitored closely. When used in combination with other antihypertensives or non-steroidal anti-inflammatory drugs, the drug's efficacy may be reduced or renal function may be affected, so consultation with healthcare professionals is advised. This medication is not recommended for breastfeeding women, and if it must be taken, cessation of breastfeeding is advised. The safety and efficacy in pediatric and adolescent patients have not yet been established, so use in this age group is discouraged. In case of overdose, severe hypotension or altered consciousness may occur, requiring immediate medical attention for appropriate treatment. Keep out of reach of children and do not transfer to other containers to maintain the drug's quality.
Urticaria, severe swelling (edema), angioedema (swelling of the face, lips, throat, tongue), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reaction, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, severe skin abnormal reactions, shortness of breath or difficulty breathing, asthma attack, breathing abnormalities with cough and fever, jaundice (yellowing of the skin or eyes), profound lethargy
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture; therefore, it should be stored in a sealed container. Additionally, it is important to store it in a cool place below 30 degrees Celsius to maintain its efficacy.
Light red round film-coated tablet
98 tablets (14 tablets/PTP packaging x 7), 30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Valsartan
Prescription medication
Hallym Pharmaceutical Co., Ltd.

Valsartan 80mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 160mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 40mg
Tablet · Prescription medication
Samsung Novartis Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan 320mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.